{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T06:53:38Z","timestamp":1768546418730,"version":"3.49.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T00:00:00Z","timestamp":1750291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T00:00:00Z","timestamp":1750291200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001691","name":"the Japan Society for the Promotion of Science KAKENHI","doi-asserted-by":"crossref","award":["JP24K20246"],"award-info":[{"award-number":["JP24K20246"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Saf"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s40264-025-01572-3","type":"journal-article","created":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T02:11:19Z","timestamp":1750299079000},"page":"1243-1251","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Identifying New Candidate Predictors of Mortality in Japanese Patients with Severe Drug Eruptions"],"prefix":"10.1007","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9475-7818","authenticated-orcid":false,"given":"Shiho","family":"Sato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadao","family":"Ooka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshito","family":"Zamami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirofumi","family":"Hamano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumikazu","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eri","family":"Eguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narumi","family":"Funakubo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Ohira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,19]]},"reference":[{"key":"1572_CR1","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.jdermsci.2020.02.003","volume":"98","author":"C Wan","year":"2020","unstructured":"Wan C, Wang H, Wang ZQ, Weintraub J, Whale C, Wheatley LM, Whyte-Croasdaile S, Williams KB, Wright G, Yeung SN, Zhou L, Chung WH, Phillips EJ, Carleton BC. SJS\/TEN 2019: from science to translation. J Dermatol Sci. 2020;98:2\u201312. https:\/\/doi.org\/10.1016\/j.jdermsci.2020.02.003.","journal-title":"J Dermatol Sci"},{"key":"1572_CR2","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1750-1172-5-39","volume":"5","author":"T Harr","year":"2010","unstructured":"Harr T, French LE. Toxic epidermal necrolysis and Stevens-Johnson syndrome. Orphanet J Rare Dis. 2010;5:39. https:\/\/doi.org\/10.1186\/1750-1172-5-39.","journal-title":"Orphanet J Rare Dis"},{"key":"1572_CR3","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/j.burns.2014.02.006","volume":"40","author":"PD Mahar","year":"2014","unstructured":"Mahar PD, Wasiak J, Hii B, Cleland H, Watters DA, Gin D, Spinks AB. A systematic review of the management and outcome of toxic epidermal necrolysis treated in burns centres. Burns. 2014;40:1245\u201354. https:\/\/doi.org\/10.1016\/j.burns.2014.02.006.","journal-title":"Burns"},{"key":"1572_CR4","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.jdermsci.2020.09.009","volume":"100","author":"Y Watanabe","year":"2020","unstructured":"Watanabe Y, Yamaguchi Y, Aihara M, Mizukawa Y, Ohyama M, Hama N, Abe R, Hashizume H, Nakajima S, Nomura T, Kabashima K, Tohyama M, Takahashi H, Mieno H, Ueta M, Sotozono C, Niihara H, Morita E, Kokaze A. The nationwide epidemiological survey of Stevens-Johnson syndrome and toxic epidermal necrolysis in Japan, 2016\u20132018. J Dermatol Sci. 2020;100:175\u201382. https:\/\/doi.org\/10.1016\/j.jdermsci.2020.09.009.","journal-title":"J Dermatol Sci"},{"key":"1572_CR5","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1097\/01.fpc.0000199500.46842.4a","volume":"16","author":"SI Hung","year":"2006","unstructured":"Hung SI, Chung WH, Jee SH, Chen WC, Chang YT, Lee WR, Hu SL, Wu MT, Chen GS, Wong TW, Hsiao PF, Chen WH, Shih HY, Fang WH, Wei CY, Lou YH, Huang YL, Lin JJ, Chen YT. Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions. Pharmacogenet Genomics. 2006;16:297\u2013306. https:\/\/doi.org\/10.1097\/01.fpc.0000199500.46842.4a.","journal-title":"Pharmacogenet Genomics"},{"key":"1572_CR6","doi-asserted-by":"publisher","first-page":"S158","DOI":"10.1097\/ICO.0000000000000605","volume":"34","author":"M Ueta","year":"2015","unstructured":"Ueta M. Genetic predisposition to Stevens-Johnson syndrome with severe ocular surface complications. Cornea. 2015;34:S158\u201365. https:\/\/doi.org\/10.1097\/ICO.0000000000000605.","journal-title":"Cornea"},{"key":"1572_CR7","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.tjo.2016.06.001","volume":"6","author":"M Ueta","year":"2016","unstructured":"Ueta M. Cold medicine-related Stevens-Johnson syndrome\/toxic epidermal necrolysis with severe ocular complications-phenotypes and genetic predispositions. Taiwan J Ophthalmol. 2016;6:108\u201318. https:\/\/doi.org\/10.1016\/j.tjo.2016.06.001.","journal-title":"Taiwan J Ophthalmol."},{"key":"1572_CR8","doi-asserted-by":"publisher","first-page":"201","DOI":"10.2217\/pme-2022-0126","volume":"20","author":"SK Das","year":"2023","unstructured":"Das SK, Sampath A, Zaman SU, Pati AK, Atal S. Genetic predisposition for the development of lamotrigine-induced Stevens-Johnson syndrome\/toxic epidermal necrolysis: a systematic review and meta-analysis. Per Med. 2023;20:201\u201313. https:\/\/doi.org\/10.2217\/pme-2022-0126.","journal-title":"Per Med"},{"key":"1572_CR9","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1046\/j.1523-1747.2000.00061.x","volume":"115","author":"S Bastuji-Garin","year":"2000","unstructured":"Bastuji-Garin S, Fouchard N, Bertocchi M, Roujeau JC, Revuz J, Wolkenstein P. SCORTEN: a severity-of-illness score for toxic epidermal necrolysis. J Invest Dermatol. 2000;115:149\u201353. https:\/\/doi.org\/10.1046\/j.1523-1747.2000.00061.x.","journal-title":"J Invest Dermatol"},{"key":"1572_CR10","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1177\/2042098611404094","volume":"2","author":"JC Roujeau","year":"2011","unstructured":"Roujeau JC, Bastuji-Garin S. Systematic review of treatments for Stevens-Johnson syndrome and toxic epidermal necrolysis using the SCORTEN score as a tool for evaluating mortality. Ther Adv Drug Saf. 2011;2:87\u201394. https:\/\/doi.org\/10.1177\/2042098611404094.","journal-title":"Ther Adv Drug Saf."},{"key":"1572_CR11","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1001\/jamadermatol.2018.5605","volume":"155","author":"MH Noe","year":"2019","unstructured":"Noe MH, Rosenbach M, Hubbard RA, Mostaghimi A, Cardones AR, Chen JK, Cotliar J, Davis MDP, Dominguez A, Fox LP, Hughey LC, Kaffenberger BH, Kroshinsky D, Kwong BY, Miller DD, Musiek A, Ortega-Loayza AG, Sharon VR, Shinkai K, Summers EM, Wanat KA, Wetter DA, Worswick S, Margolis DJ, Gelfand JM, Micheletti RG. Development and validation of a risk prediction model for in-hospital mortality among patients with Stevens-Johnson syndrome\/toxic epidermal necrolysis\u2014ABCD-10. JAMA Dermatol. 2019;155:448\u201354. https:\/\/doi.org\/10.1001\/jamadermatol.2018.5605.","journal-title":"JAMA Dermatol"},{"key":"1572_CR12","volume":"12","author":"T von Wild","year":"2012","unstructured":"von Wild T, Stollwerck PL, Namdar T, Stang FH, Mail\u00e4nder P, Siemers F. Are multimorbidities underestimated in scoring systems of Stevens-Johnson syndrome and toxic epidermal necrolysis like in SCORTEN? Eplasty. 2012;12: e35.","journal-title":"Eplasty"},{"key":"1572_CR13","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1016\/j.jid.2018.04.027","volume":"138","author":"RG Micheletti","year":"2018","unstructured":"Micheletti RG, Chiesa-Fuxench Z, Noe MH, Stephen S, Aleshin M, Agarwal A, Boggs J, Cardones AR, Chen JK, Cotliar J, Davis MDP, Dominguez A, Fox LP, Gordon S, Hamrick R, Ho B, Hughey LC, Jones LM, Kaffenberger BH, Kindley K, Kroshinsky D, Kwong BY, Miller DD, Mostaghimi A, Musiek A, Ortega-Loayza AG, Patel R, Posligua A, Rani M, Saluja S, Sharon VR, Shinkai K, John JS, Strickland N, Summers EM, Sun N, Wanat KA, Wetter DA, Worswick S, Yang C, Margolis DJ, Gelfand JM, Rosenbach M. Stevens-Johnson syndrome\/toxic epidermal necrolysis: a multicenter retrospective study of 377 adult patients from the United States. J Invest Dermatol. 2018;138:2315\u201321. https:\/\/doi.org\/10.1016\/j.jid.2018.04.027.","journal-title":"J Invest Dermatol"},{"key":"1572_CR14","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.alit.2015.09.001","volume":"65","author":"Y Yamane","year":"2016","unstructured":"Yamane Y, Matsukura S, Watanabe Y, Yamaguchi Y, Nakamura K, Kambara T, Ikezawa Z, Aihara M. Retrospective analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis in 87 Japanese patients\u2013Treatment and outcome. Allergol Int. 2016;65:74\u201381. https:\/\/doi.org\/10.1016\/j.alit.2015.09.001.","journal-title":"Allergol Int"},{"key":"1572_CR15","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.alit.2020.11.004","volume":"70","author":"T Watanabe","year":"2021","unstructured":"Watanabe T, Go H, Saigusa Y, Takamura N, Watanabe Y, Yamane Y, Totsuka M, Ishikawa H, Nakamura K, Matsukura S, Kambara T, Takaki S, Yamaguchi Y, Aihara M. Mortality and risk factors on admission in toxic epidermal necrolysis: a cohort study of 59 patients. Allergol Int. 2021;70:229\u201334. https:\/\/doi.org\/10.1016\/j.alit.2020.11.004.","journal-title":"Allergol Int"},{"key":"1572_CR16","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1001\/jamadermatol.2020.3654","volume":"156","author":"HK Koh","year":"2020","unstructured":"Koh HK, Fook-Chong S, Lee HY. Assessment and comparison of performance of ABCD-10 and SCORTEN in prognostication of epidermal necrolysis. JAMA Dermatol. 2020;156:1294\u20139. https:\/\/doi.org\/10.1001\/jamadermatol.2020.3654.","journal-title":"JAMA Dermatol"},{"key":"1572_CR17","doi-asserted-by":"publisher","first-page":"3161","DOI":"10.1016\/j.jaip.2023.07.001","volume":"11","author":"N Hama","year":"2023","unstructured":"Hama N, Sunaga Y, Ochiai H, Kokaze A, Watanabe H, Kurosawa M, Azukizawa H, Asada H, Watanabe Y, Yamaguchi Y, Aihara M, Mizukawa Y, Ohyama M, Hashizume H, Nakajima S, Nomura T, Kabashima K, Tohyama M, Hasegawa A, Takahashi H, Mieno H, Ueta M, Sotozono C, Niihara H, Morita E, Br\u00fcggen MC, Feingold IM, Jeschke MG, Dodiuk-Gad RP, Oppel EM, French LE, Chen WT, Chung WH, Chu CY, Kang HR, Ingen-Housz-Oro S, Nakamura K, Sueki H, Abe R. Development and validation of a novel score to predict mortality in Stevens-Johnson syndrome and toxic epidermal necrolysis: CRISTEN. J Allergy Clin Immunol Pract. 2023;11:3161\u20138. https:\/\/doi.org\/10.1016\/j.jaip.2023.07.001.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"1572_CR18","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1001\/jamadermatol.2021.5119","volume":"158","author":"HK Koh","year":"2022","unstructured":"Koh HK, Fook-Chong SMC, Lee HY. Improvement of mortality prognostication in patients with epidermal necrolysis: the role of novel inflammatory markers and proposed revision of SCORTEN (Re-SCORTEN). JAMA Dermatol. 2022;158:160\u20136. https:\/\/doi.org\/10.1001\/jamadermatol.2021.5119.","journal-title":"JAMA Dermatol"},{"key":"1572_CR19","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s13181-015-0472-1","volume":"11","author":"KK Burkhart","year":"2015","unstructured":"Burkhart KK, Abernethy D, Jackson D. Data mining FAERS to analyze molecular targets of drugs highly associated with Stevens-Johnson syndrome. J Med Toxicol. 2015;11:265\u201373. https:\/\/doi.org\/10.1007\/s13181-015-0472-1.","journal-title":"J Med Toxicol"},{"key":"1572_CR20","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s40780-016-0048-5","volume":"2","author":"J Abe","year":"2016","unstructured":"Abe J, Umetsu R, Mataki K, Kato Y, Ueda N, Nakayama Y, Hane Y, Matsui T, Hatahira H, Sasaoka S, Motooka Y, Hara H, Kato Z, Kinosada Y, Inagaki N, Nakamura M. Analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis using the Japanese Adverse Drug Event Report database. J Pharm Health Care Sci. 2016;2:14. https:\/\/doi.org\/10.1186\/s40780-016-0048-5.","journal-title":"J Pharm Health Care Sci."},{"key":"1572_CR21","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1093\/jamia\/ocv127","volume":"23","author":"YS Low","year":"2016","unstructured":"Low YS, Caster O, Bergvall T, Fourches D, Zang X, Nor\u00e9n GN, Rusyn I, Edwards R, Tropsha A. Cheminformatics-aided pharmacovigilance: application to Stevens-Johnson Syndrome. J Am Med Inform Assoc. 2016;23:968\u201378. https:\/\/doi.org\/10.1093\/jamia\/ocv127.","journal-title":"J Am Med Inform Assoc"},{"key":"1572_CR22","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1208\/s12248-016-9898-x","volume":"18","author":"R Chan","year":"2016","unstructured":"Chan R, Wei CY, Chen YT, Benet LZ. Use of the biopharmaceutics drug disposition classification system (BDDCS) to help predict the occurrence of idiosyncratic cutaneous adverse drug reactions associated with antiepileptic drug usage. AAPS J. 2016;18:757\u201366. https:\/\/doi.org\/10.1208\/s12248-016-9898-x.","journal-title":"AAPS J"},{"key":"1572_CR23","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/cpt.1071","volume":"105","author":"YH Wang","year":"2019","unstructured":"Wang YH, Chen CB, Tassaneeyakul W, Saito Y, Aihara M, Choon SE, Lee HY, Chang MM, Roa FD, Wu CW, Zhang J, Nakkam N, Konyoung P, Okamoto-Uchida Y, Cheung CM, Huang JW, Ji C, Cheng B, Hui RC, Chu CY, Chen YJ, Wu CY, Hsu CK, Chiu TM, Huang YH, Lu CW, Yang CY, Lin YT, Chi MH, Ho HC, Lin JY, Yang CH, Chang YC, Su SC, Wang CW, Fan WL, Hung SI, Chung WH, Asian Severe Cutaneous Adverse Reaction Consortium. The medication risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in asians: the major drug causality and comparison with the US FDA label. Clin Pharmacol Ther. 2019;105:112\u201320. https:\/\/doi.org\/10.1002\/cpt.1071.","journal-title":"Clin Pharmacol Ther"},{"key":"1572_CR24","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1111\/cts.12944","volume":"14","author":"K Ambe","year":"2021","unstructured":"Ambe K, Ohya K, Takada W, Suzuki M, Tohkin M. In silico approach to predict severe cutaneous adverse reactions using the Japanese adverse drug event report database. Clin Transl Sci. 2021;14:756\u201363. https:\/\/doi.org\/10.1111\/cts.12944.","journal-title":"Clin Transl Sci"},{"key":"1572_CR25","unstructured":"https:\/\/www.pmda.go.jp\/safety\/info-services\/drugs\/adr-info\/suspected-adr\/0003.html. Accessed 21 Jan 2024 (Japanese)."},{"key":"1572_CR26","unstructured":"https:\/\/www.jmo.gr.jp\/jmo\/servlet\/mdrLoginTop. Accessed 21 Apr 2022 (Japanese)."},{"key":"1572_CR27","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1097\/00004630-199111000-00015","volume":"12","author":"MH Jordan","year":"1991","unstructured":"Jordan MH, Lewis MS, Jeng JG, Rees JM. Treatment of toxic epidermal necrolysis by burn units: another market or another threat? J Burn Care Rehabil. 1991;12:579\u201381. https:\/\/doi.org\/10.1097\/00004630-199111000-00015.","journal-title":"J Burn Care Rehabil"},{"key":"1572_CR28","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/sj.jid.5701033","volume":"128","author":"M Mockenhaupt","year":"2008","unstructured":"Mockenhaupt M, Viboud C, Dunant A, Naldi L, Halevy S, Bouwes Bavinck JN, Sidoroff A, Schneck J, Roujeau JC, Flahault A. Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study. J Investig Dermatol. 2008;128:35\u201344. https:\/\/doi.org\/10.1038\/sj.jid.5701033.","journal-title":"J Investig Dermatol"},{"key":"1572_CR29","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s12016-017-8654-z","volume":"54","author":"M Lerch","year":"2018","unstructured":"Lerch M, Mainetti C, Terziroli Beretta-Piccoli B, Harr T. Current perspectives on Stevens-Johnson syndrome and toxic epidermal necrolysis. Clin Rev Allergy Immunol. 2018;54:147\u201376. https:\/\/doi.org\/10.1007\/s12016-017-8654-z.","journal-title":"Clin Rev Allergy Immunol"},{"key":"1572_CR30","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.17527","author":"TJ Stewart","year":"2024","unstructured":"Stewart TJ, Chan CJ, Shah H, Frew J. Infectious complications of Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis. Int J Dermatol. 2024. https:\/\/doi.org\/10.1111\/ijd.17527.","journal-title":"Int J Dermatol"},{"key":"1572_CR31","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.jdermsci.2020.09.009","volume":"100","author":"Y Sunaga","year":"2020","unstructured":"Sunaga Y, Kurosawa M, Ochiai H, Watanabe H, Sueki H, Azukizawa H, Asada H, Watanabe Y, Yamaguchi Y, Aihara M, Mizukawa Y, Ohyama M, Hama N, Abe R, Hashizume H, Nakajima S, Nomura T, Kabashima K, Tohyama M, Takahashi H, Mieno H, Ueta M, Sotozono C, Niihara H, Morita E, Kokaze A. The nationwide epidemiological survey of Stevens-Johnson syndrome and toxic epidermal necrolysis in Japan, 2016\u20132018. J Dermatol Sci. 2020;100:175\u201382. https:\/\/doi.org\/10.1016\/j.jdermsci.2020.09.009.","journal-title":"J Dermatol Sci"},{"key":"1572_CR32","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s001340050041","volume":"26","author":"MW Wichmann","year":"2000","unstructured":"Wichmann MW, Inthorn D, Andress HJ, Schildberg FW. Incidence and mortality of severe sepsis in surgical intensive care patients: the influence of patient gender on disease process and outcome. Intensive Care Med. 2000;26:167\u201372. https:\/\/doi.org\/10.1007\/s001340050041.","journal-title":"Intensive Care Med"},{"key":"1572_CR33","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1097\/00003246-199701000-00021","volume":"25","author":"R Zellweger","year":"1997","unstructured":"Zellweger R, Wichmann MW, Ayala A, Stein S, DeMaso CM, Chaudry IH. Females in proestrus state maintain splenic immune functions and tolerate sepsis better than males. Crit Care Med. 1997;25:106\u201310. https:\/\/doi.org\/10.1097\/00003246-199701000-00021.","journal-title":"Crit Care Med"},{"key":"1572_CR34","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.jinf.2022.04.035","volume":"84","author":"KJ Thompson","year":"2022","unstructured":"Thompson KJ, Finfer SR, Woodward M, Leong RNF, Liu B. Sex differences in sepsis hospitalisations and outcomes in older women and men: a prospective cohort study. J Infect. 2022;84:770\u20136. https:\/\/doi.org\/10.1016\/j.jinf.2022.04.035.","journal-title":"J Infect"},{"key":"1572_CR35","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1186\/s13054-016-1579-8","volume":"20","author":"FW Guirgis","year":"2016","unstructured":"Guirgis FW, Donnelly JP, Dodani S, Howard G, Safford MM, Levitan EB, Wang HE. Cholesterol levels and long-term rates of community-acquired sepsis. Crit Care. 2016;20:408. https:\/\/doi.org\/10.1186\/s13054-016-1579-8.","journal-title":"Crit Care"},{"key":"1572_CR36","doi-asserted-by":"publisher","first-page":"eabl9322","DOI":"10.1126\/scisignal.abl9322","volume":"15","author":"L Guo","year":"2022","unstructured":"Guo L, Morin EE, Yu M, Mei L, Fawaz MV, Wang Q, Yuan Y, Zhan CG, Standiford TJ, Schwendeman A, Li XA. Replenishing HDL with synthetic HDL has multiple protective effects against sepsis in mice. Sci Signal. 2022;15:eabl9322. https:\/\/doi.org\/10.1126\/scisignal.abl9322.","journal-title":"Sci Signal"},{"key":"1572_CR37","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1164\/rccm.202105-1197TR","volume":"205","author":"DA Hofmaenner","year":"2022","unstructured":"Hofmaenner DA, Kleyman A, Press A, Bauer M, Singer M. The many roles of cholesterol in sepsis: a review. Am J Respir Crit Care Med. 2022;205:388\u201396. https:\/\/doi.org\/10.1164\/rccm.202105-1197TR.","journal-title":"Am J Respir Crit Care Med"},{"key":"1572_CR38","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-026171","volume":"9","author":"B Porter","year":"2019","unstructured":"Porter B, Arthur A, Savva GM. How do potentially inappropriate medications and polypharmacy affect mortality in frail and non-frail cognitively impaired older adults? A cohort study. BMJ Open. 2019;9: e026171. https:\/\/doi.org\/10.1136\/bmjopen-2018-026171.","journal-title":"BMJ Open"},{"key":"1572_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.archger.2022.104630","volume":"100","author":"Y Li","year":"2022","unstructured":"Li Y, Zhang X, Yang L, Yang Y, Qiao G, Lu C, Liu K. Association between polypharmacy and mortality in the older adults: a systematic review and meta-analysis. Arch Gerontol Geriatr. 2022;100: 104630. https:\/\/doi.org\/10.1016\/j.archger.2022.104630.","journal-title":"Arch Gerontol Geriatr"}],"container-title":["Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-025-01572-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40264-025-01572-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-025-01572-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T19:03:20Z","timestamp":1760209400000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40264-025-01572-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,19]]},"references-count":39,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["1572"],"URL":"https:\/\/doi.org\/10.1007\/s40264-025-01572-3","relation":{},"ISSN":["0114-5916","1179-1942"],"issn-type":[{"value":"0114-5916","type":"print"},{"value":"1179-1942","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,19]]},"assertion":[{"value":"3 June 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This work was supported by JSPS KAKENHI (grant number: JP24K20246).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"Ethical approval was not required as this study used publicly available data from the JADER database.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The data used in this study were obtained from the publicly available JADER database, which is managed by the Pharmaceuticals and Medical Devices Agency (PMDA). The dataset can be accessed through the following link:  (accessed on 7 Jan 2025) (only in Japanese).","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data Availability"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"Conceptualization: Shiho Sato, Tetsuya Ohira. Data curation: Shiho Sato; Formal analysis: Shiho Sato; Funding acquisition: Shiho Sato; Investigation: Shiho Sato, Tetsuya Ohira, Tadao Ooka, Yoshito Zamami, Hirofumi Hamano; Methodology: Shiho Sato, Tetsuya Ohira, Tadao Ooka, Yoshito Zamami, Hirofumi Hamano; Project administration: Shiho Sato, Tetsuya Ohira; Resources: N\/A. Software: N\/A; Supervision: Tetsuya Ohira and Yoshito Zamami; Validation: Fumikazu Hayashi, Eri Eguchi, Narumi Funakubo; Visualization: Shiho Sato; Writing \u2013 original draft: Shiho Sato; Writing \u2013 review & editing: Tetsuya Ohira, Tadao Ooka, Yoshito Zamami, Hirofumi Hamano, Fumikazu Hayashi, Eri Eguchi, Narumi Funakubo. Author Statement: All authors have read and agreed to the submitted version of the manuscript.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author Contributions"}}]}}